Mark Worthington - Net Worth and Insider Trading
Mark Worthington Net Worth
The estimated net worth of Mark Worthington is at least $33,686 dollars as of 2025-07-03. Mark Worthington is the General Counsel and CCO of Athira Pharma Inc and owns about 111,875 shares of Athira Pharma Inc (ATHA) stock worth over $33,686. Details can be seen in Mark Worthington's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mark Worthington has not made any transactions after 2025-07-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Mark Worthington
Mark Worthington Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mark Worthington owns 1 companies in total, including Athira Pharma Inc (ATHA) .
Click here to see the complete history of Mark Worthington’s form 4 insider trades.
Insider Ownership Summary of Mark Worthington
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| ATHA | Athira Pharma Inc | 2025-07-01 | General Counsel |
Mark Worthington Latest Holdings Summary
Mark Worthington currently owns a total of 1 stock. Mark Worthington owns 111,875 shares of Athira Pharma Inc (ATHA) as of July 1, 2025, with a value of $33,686.
Latest Holdings of Mark Worthington
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ATHA | Athira Pharma Inc | 2025-07-01 | 111,875 | 0.30 | 33,686 |
Holding Weightings of Mark Worthington
Mark Worthington Form 4 Trading Tracker
According to the SEC Form 4 filings, Mark Worthington has made a total of 6 transactions in Athira Pharma Inc (ATHA) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Athira Pharma Inc is the sale of 8,526 shares on July 1, 2025, which brought Mark Worthington around $2,473.
Insider Trading History of Mark Worthington
- 1
Mark Worthington Trading Performance
Mark Worthington Ownership Network
Ownership Network List of Mark Worthington
Ownership Network Relation of Mark Worthington
Mark Worthington Owned Company Details
What does Athira Pharma Inc do?
Who are the key executives at Athira Pharma Inc?
Mark Worthington is the General Counsel of Athira Pharma Inc. Other key executives at Athira Pharma Inc include Chief Operating Officer Mark James Litton , Vice President of Discovery Kevin Church , and See Below Andrew Gengos .
Athira Pharma Inc (ATHA) Insider Trades Summary
Over the past 18 months, Mark Worthington made 5 insider transaction in Athira Pharma Inc (ATHA) with a net sale of 24,385. Other recent insider transactions involving Athira Pharma Inc (ATHA) include a net sale of 64,902 shares made by Mark James Litton , a net sale of 21,973 shares made by Kevin Church , and a net sale of 7,349 shares made by Rachel Lenington .
In summary, during the past 3 months, insiders sold 55,914 shares of Athira Pharma Inc (ATHA) in total and bought 0 shares, with a net sale of 55,914 shares. During the past 18 months, 148,535 shares of Athira Pharma Inc (ATHA) were sold and 42,400 shares were bought by its insiders, resulting in a net sale of 106,135 shares.
Athira Pharma Inc (ATHA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Athira Pharma Inc Insider Transactions
Mark Worthington Mailing Address
Above is the net worth, insider trading, and ownership report for Mark Worthington. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Mark Worthington's mailing address is: Bothell Wa 98011.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
